![Vaccines | Free Full-Text | Effectiveness of the Booster of SARS-CoV-2 Vaccine among Japanese Adolescents: A Cohort Study Vaccines | Free Full-Text | Effectiveness of the Booster of SARS-CoV-2 Vaccine among Japanese Adolescents: A Cohort Study](https://www.mdpi.com/vaccines/vaccines-10-01914/article_deploy/html/images/vaccines-10-01914-g001.png)
Vaccines | Free Full-Text | Effectiveness of the Booster of SARS-CoV-2 Vaccine among Japanese Adolescents: A Cohort Study
![Study highlights the importance of bivalent mRNA booster vaccination in populations at high risk of severe COVID-19 Study highlights the importance of bivalent mRNA booster vaccination in populations at high risk of severe COVID-19](https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_745226_16817225096615479.jpg)
Study highlights the importance of bivalent mRNA booster vaccination in populations at high risk of severe COVID-19
![Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet](https://www.thelancet.com/cms/attachment/97d1c5ff-af79-4d10-b5b8-3026a35a572d/gr1_lrg.jpg)
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet
![Monovalent and bivalent COVID boosters provide strong protection against severe outcomes in older adults Monovalent and bivalent COVID boosters provide strong protection against severe outcomes in older adults](https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_745095_16814788526283575.jpg)
Monovalent and bivalent COVID boosters provide strong protection against severe outcomes in older adults
![Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study - The Lancet Respiratory Medicine Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/cb26e910-dc14-4b32-a123-110b22c44f1e/gr1.jpg)
Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study - The Lancet Respiratory Medicine
![Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01832-0/MediaObjects/41591_2022_1832_Fig1_HTML.png)
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine
![One in 13 Covid double-jabbed in UK reluctant to get booster, study finds | Vaccines and immunisation | The Guardian One in 13 Covid double-jabbed in UK reluctant to get booster, study finds | Vaccines and immunisation | The Guardian](https://i.guim.co.uk/img/media/b3ae928d8e47549f4a0f4ab2c922cc2382c0d10d/0_0_2335_1401/master/2335.jpg?width=1200&height=1200&quality=85&auto=format&fit=crop&s=994a097fe2cc28202d5239b9a1db59fe)
One in 13 Covid double-jabbed in UK reluctant to get booster, study finds | Vaccines and immunisation | The Guardian
![Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial | Nature Medicine Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial | Nature Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-022-02031-7/MediaObjects/41591_2022_2031_Fig1_HTML.png)